DE LUCA, Michele
 Distribuzione geografica
Continente #
NA - Nord America 23.434
EU - Europa 10.492
AS - Asia 9.782
SA - Sud America 1.290
Continente sconosciuto - Info sul continente non disponibili 365
AF - Africa 181
OC - Oceania 71
Totale 45.615
Nazione #
US - Stati Uniti d'America 22.940
GB - Regno Unito 4.109
SG - Singapore 2.803
CN - Cina 2.701
IT - Italia 2.376
HK - Hong Kong 1.370
BR - Brasile 1.006
SE - Svezia 859
VN - Vietnam 839
DE - Germania 630
FI - Finlandia 480
UA - Ucraina 458
BD - Bangladesh 423
TR - Turchia 367
FR - Francia 361
RU - Federazione Russa 324
KR - Corea 312
CA - Canada 272
IN - India 198
BG - Bulgaria 168
SI - Slovenia 166
JP - Giappone 141
ID - Indonesia 131
NL - Olanda 130
AR - Argentina 90
MX - Messico 76
PL - Polonia 76
IQ - Iraq 66
ZA - Sudafrica 63
ES - Italia 55
AE - Emirati Arabi Uniti 52
IE - Irlanda 49
PK - Pakistan 49
EC - Ecuador 45
CO - Colombia 44
BE - Belgio 40
IR - Iran 39
CL - Cile 38
AU - Australia 37
AT - Austria 36
NZ - Nuova Zelanda 34
PH - Filippine 34
UZ - Uzbekistan 34
SA - Arabia Saudita 30
TW - Taiwan 30
LT - Lituania 28
CZ - Repubblica Ceca 27
MY - Malesia 27
MA - Marocco 26
VE - Venezuela 26
CR - Costa Rica 25
EG - Egitto 22
DK - Danimarca 21
RO - Romania 20
HN - Honduras 18
JM - Giamaica 18
TH - Thailandia 17
DZ - Algeria 16
IL - Israele 14
JO - Giordania 14
QA - Qatar 14
SV - El Salvador 14
TT - Trinidad e Tobago 14
KE - Kenya 13
KZ - Kazakistan 13
NI - Nicaragua 13
TN - Tunisia 13
CH - Svizzera 12
PT - Portogallo 12
PY - Paraguay 12
UY - Uruguay 12
NP - Nepal 11
PE - Perù 11
EU - Europa 9
GT - Guatemala 9
AZ - Azerbaigian 8
AL - Albania 7
DO - Repubblica Dominicana 7
BY - Bielorussia 6
EE - Estonia 6
ET - Etiopia 6
HU - Ungheria 6
KW - Kuwait 6
PS - Palestinian Territory 6
RS - Serbia 6
MD - Moldavia 5
OM - Oman 5
PA - Panama 5
PR - Porto Rico 5
SC - Seychelles 5
GP - Guadalupe 4
GR - Grecia 4
KG - Kirghizistan 4
LK - Sri Lanka 4
NO - Norvegia 4
SK - Slovacchia (Repubblica Slovacca) 4
AM - Armenia 3
BB - Barbados 3
BO - Bolivia 3
CG - Congo 3
Totale 45.207
Città #
Southend 3.199
Ashburn 3.019
Santa Clara 1.902
Singapore 1.624
Fairfield 1.552
Hong Kong 1.342
Woodbridge 1.321
San Jose 1.149
Chandler 1.029
Houston 1.008
Jacksonville 963
Hefei 772
Dearborn 697
Council Bluffs 651
Ann Arbor 620
Wilmington 582
Cambridge 561
Seattle 559
Beijing 491
London 442
Nyköping 385
Los Angeles 377
Sunnyvale 377
The Dalles 321
Helsinki 309
Seoul 254
Ho Chi Minh City 250
Milan 237
Chicago 221
Hanoi 217
New York 217
Modena 215
San Diego 190
Izmir 180
Princeton 180
Columbus 170
Sofia 166
Eugene 151
Rome 146
Lauterbourg 140
Buffalo 137
Des Moines 125
São Paulo 125
Bologna 110
Bari 104
Dallas 98
Moscow 96
Shanghai 91
Jakarta 86
Redwood City 82
Falls Church 81
Munich 80
Phoenix 73
Salt Lake City 70
Tokyo 69
Toronto 69
Boardman 61
Orem 54
Atlanta 50
Brooklyn 49
Norwalk 48
Frankfurt am Main 46
Montreal 42
Warsaw 41
Bremen 39
Dublin 38
Guangzhou 37
Haiphong 36
Brasília 35
Tampa 34
Denver 32
Kent 32
Naples 31
Elk Grove Village 30
San Francisco 30
Changsha 29
Auckland 28
Da Nang 28
Lansdowne 28
Tashkent 28
Xi'an 28
Belo Horizonte 27
Brussels 27
Chennai 27
Nanjing 27
Rio de Janeiro 27
Formigine 26
Mexico City 26
Miano 26
North Bergen 26
Paris 26
Reggio Emilia 26
Baghdad 25
Boston 25
Philadelphia 25
Amsterdam 24
Falkenstein 24
Glasgow 24
Turin 24
Catania 23
Totale 31.101
Nome #
Regeneration of the entire human epidermis using transgenic stem cells 937
Closure of a Large Chronic Wound through Transplantation of Gene-Corrected Epidermal Stem Cells 616
Epithelial stem cells in corneal regeneration and epidermal gene therapy 586
Holoclar: first of its kind in more ways than one 562
Applicazioni cliniche dei cheratinociti umani normali coltivati in vitro 503
Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells 480
Aberrant splicing in the ocular albinism type 1 gene (OA1/GPR143) is corrected in vitro by morpholino antisense oligonucleotides 470
Comparative assessment of cultures from oral and urethral stem cells for urethral regeneration 456
Concise review: hurdles in a successful example of limbal stem cell-based regenerative medicine 408
Long-term stability and safety of transgenic cultured epidermal stem cells in gene therapy of junctional epidermolysis bullosa. 402
Correction of recessive dystrophic epidermolysis bullosa by transposon-mediated integration of COL7A1 in transplantable patient-derived primary keratinocytes. 399
Laminin 332-Dependent YAP Dysregulation Depletes Epidermal Stem Cells in Junctional Epidermolysis Bullosa 398
Advances in stem cell research and therapeutic development 394
Polarized expression of integrin receptors (a6b4, a2b1, a3b1, avb5) and their relationshipwith the cytoskeleton and basement membrane matrix in cultured human keratinocytes. [5YIF: 10.77; Citations: 127] 393
Amplicon-based next-generation sequencing: an effective approach for the molecular diagnosis of epidermolysis bullosa 389
Biological parameters determining the clinical outcome of autologous cultures of limbal stem cells 388
Amplicon-based Next Generation Sequencing: an effective approach to molecular diagnosis of Epidermolysis Bullosa 387
Autologous fibrin-cultured limbal stem cells permanently restore the corneal surface of patients with total limbal stem cell deficiency 382
Advances in Gene/Cell Therapy in Epidermolysis Bullosa 376
A volume-sensitive chloride conductance revealed in cultured human keratinocytes by 36Cl- efflux and whole-cell patch clamp recording 367
The control of epidermal stem cells (holoclones) in the treatment of massive full-thickness burns with autologous keratinocytes cultured on fibrin. [5YIF: 3.60, Citations: 215] 365
Ultrasensitive in vivo bioassay detects bioactive human growth hormone in transduced primary human keratinocytes 359
Gentamicin induces LAMB3 nonsense mutation readthrough and restores functional laminin 332 in junctional epidermolysis bullosa 358
Isolation of human keratinocyte stem cells and high-throughput screening approach for their characterization 357
"HepG2/erythroid/brain" type glucose transporter (GLUT1) is highly expressed in human epidermis: keratinocyte differentiation affects GLUT1 levels in reconstituted epidermis 343
Allele specific CRISPR/Cas9 editing of dominant Epidermolysis Bullosa Simplex in human epidermal stem cells 340
Q-FIHC: Quantification of fluorescence immunohistochemistry to analyse p63 isoforms and cell cycle phases in human limbal stem cells 331
C/EBPδ regulates cell cycle and self-renewal of human limbal stem cells. 328
Navigating Market Authorization: The Path Holoclar Took to Become the First Stem Cell Product Approved in the European Union 328
Gene therapy in combination with tissue engineering to treat epidermolysis bullosa 327
The long and winding road that leads to a cure for epidermolysis bullosa 323
A two-stage, p16INK4A- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status 322
Corrective transduction of human epidermal stem cells in laminin-5-dependent Junctional Epidermolysis Bullosa. 322
Methods for characterization/manipulation of human corneal stem cells and their applications in regenerative medicine. 320
Separation of keratan-sulfate-derived disaccharides by high-performance liquid chromatography and postcolumn derivatization with 2-cyanoacetamide and fluorimetric detection 317
Correction of Laminin-5 Deficiency in Human Epidermal Stem Cells by Transcriptionally Targeted Lentiviral Vectors 317
Hologene 5: A Phase II/III Clinical Trial of Combined Cell and Gene Therapy of Junctional Epidermolysis Bullosa 316
Inherited epidermolysis bullosa: description of clinical and subclinical morphological features with optical coherence tomography 314
Single-keratinocyte transcriptomic analyses identify different clonal types and proliferative potential mediated by FOXM1 in human epidermal stem cells 313
p63 identifies keratinocyte stem cells 311
Gene therapy approaches for epidermolysis bullosa 310
Stem cell plasticity: time for a reappraisal? 308
Human epithelial cells induce human melanocyte growth in vitro but only skin keratinocytes regulate its proper differentiation in the absence of dermis. 308
AMPLICON-BASED NGS: AN EFFECTIVE APPROACH FOR THE MOLECULAR DIAGNOSIS OF EPIDERMOLYSIS BULLOSA 308
Clonal analysis of human clonogenic keratinocytes 308
Alpha melanocyte stimulating hormone (alpha MSH) stimulates normal human melanocyte growth by binding to high-affinity receptors 306
Chloride transport pathways in human keratinocytes 304
Toward epidermal stem cell-mediated ex vivo gene therapy of junctional epidermolysis bullosa 302
Defective intracellular transport and processing of OA1 is a major cause of ocular albinism type 1 296
Corrective gene transfer of keratinocytes from patients with junctional epidermolysis bullosa restores assembly of hemidesmosomes in reconstructed epithelia 296
Limbal stem-cell therapy and long-term corneal regeneration. 295
Role of integrins in cell adhesion and polarity in normal keratinocytes and human skin pathologies 294
A discussion on cell therapy in Manchester 289
In vitro paracrine regulation of human keratinocyte growth by fibroblast-derived insulin-like growth factors 289
Regulation of stem cell therapies under attack in Europe: for whom the bell tolls 285
Cell biology: Dormant and restless skin stem cells 283
Molecular cloning of trkE, a novel trk-related putative tyrosine kinase receptor isolated from normal human keratinocytes and widely expressed by normal human tissues. 280
Characterization of chloride transport pathways in cultured human keratinocytes 279
Corneal Bioengineering 279
A cellular disease model toward gene therapy of TGM1-dependent lamellar ichthyosis 278
HIV-1 spreads from lymphocytes to normal human keratinocytes suitable for autologous and allogenic transplantation 276
Analysis of the mechanical properties of in vitro reconstructed epidermis: preliminary results 275
Permanent repigmentation of piebaldism by erbium:YAG laser and autologous cultured epidermis 274
Topography and biological role of integrins in human skin 274
Regeneration of squamous epithelia from stem cells of cultured grafts 273
Psoriatic lesions in patients with chronic liver disease are distinct from psoriasis vulgaris lesions, as judged on basis of integrin adhesion receptors 273
Eyes on the prize: Limbal stem cells and corneal restoration 268
Expression of VSX1 in human corneal keratocytes during differentiation into myofibroblasts in response to wound healing 268
Treatment of 'stable' vitiligo by Timedsurgery transplantation of cultured epidermal autografts 268
Gene therapy of inherited skin adhesion disorders: a critical overview 266
Expression of integrin receptors and their role in adhesion, spreading and migration of normal human melanocytes 266
Ocular Albinism: evidence for a defect in an intracellular signal transduction system. 265
Towards a gene therapy clinical trial for epidermolysis bullosa 265
Transforming Growth-Factor-Beta-1 Modulates Beta-1 And Beta-5 Integrin Receptors And Induces The De-Novo Expression Of The Alpha-V-Beta-6 Heterodimer In Normal Human Keratinocytes - Implications For Wound-Healing. 265
Transforming Growth-Factor (TGF)-Beta(1) Enhances Alpha(5)Beta(1) And Alpha(V)Beta(5) Integrin Expression And Migration Of Normal Human Keratinocytes 263
Telomerase activity is sufficient to bypass replicative senescence in human limbal and conjunctival but not corneal keratinocytes 260
Isoforms of ΔNp63 and the migration of ocular limbal cells in human corneal regeneration 257
Effective retrovirus-mediated gene transfer in normal and mutant human melanocytes 255
[Inhibition of the biosynthesis of thyroglobulin with propranolol in the rat] 255
The Ocular Albinism type 1 gene product is a membrane glycoprotein localized to melanosomes. 255
Advances on potential therapeutic options for epidermolysis bullosa 254
Clonal analysis of stably transduced human epidermal stem cells in culture. 253
High expression levels of the "erythroid/brain" type glucose transporter (GLUT1) in the basal cells of human eye conjunctiva and oral mucosa reconstituted in culture 252
The importance of epidermal stem cells in keratinocyte-mediated gene therapy 251
Stamina therapies: Let the record stand 251
Treatment of leg ulcers with cryopreserved allogeneic cultured epithelium. A multicenter study 246
Erbium:YAG laser and cultured epidermis in the surgical therapy of stable vitiligo. 245
Structural and functional studies of integrin receptors in cultured human keratinocytes 245
Expression, topography and function of integrin receptors is severely altered in keratinocytes from involved and uninvolved psoriatic skin. 244
A multicenter experience in the treatment of burns with autologous and allogeneic cultured epithelium fresh or preserved in a frozen state 240
Towards therapeutic application of ocular stem cells 240
Discoidin domain receptor 1 (DDR1) signaling in PC12 cells: activation of juxtamembranedomains in PDGF/DDR/TrkA chimeric receptors. 239
[Inhibition of the biosynthesis of thyroglobulin in the thyroid gland of rats by isoniazid] 239
Cryoprotective aqueous solutions useful for the preservation of in vitro cultured epithelial cells. 237
Long term restoration of human corneal surface with autologous corneal epithelium generated by serial cultivation of limbal epithelial cells. 237
Stairways to Advanced Therapies for Epidermolysis Bullosa 236
Biochemical role of FOXM1-dependent histone linker H1B in human epidermal stem cells 235
Cultivation of human keratinocyte stem cells: current and future clinical applications 235
Human embryonic stem cell-derived keratinocytes: how close to clinics? [5YIF: 24.57; Citations: 8] 234
Permanent coverage of full skin thickness burns with autologous cultured epidermis and reepithelialization of partial skin thickness lesions induced by allogeneic cultured epidermis: a multicentre study in the treatment of children 234
Totale 31.969
Categoria #
all - tutte 162.886
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 162.886


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.450 0 0 0 284 141 250 202 173 345 218 471 366
2022/20233.174 369 339 333 233 365 475 69 285 424 43 140 99
2023/20242.028 76 128 123 159 387 128 119 271 55 225 83 274
2024/20257.304 254 98 175 478 1.276 1.146 570 379 683 271 913 1.061
2025/202611.743 759 658 983 1.073 1.231 941 1.540 624 1.182 1.183 762 807
2026/20274.770 431 1.307 1.246 1.786 0 0 0 0 0 0 0 0
Totale 45.615